Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07470125
PHASE1

Bioequivalence (BE) Study Between YHP2511 and YHP2511A in Healthy Volunteers

Sponsor: Yuhan Corporation

View on ClinicalTrials.gov

Summary

A randomized, open-label, single-dose, 2-sequence, 2-period, crossover clinical trial to investigate the bioequivalence between YHP2511 and YHP2511A in healthy volunteers

Official title: An Open-label, Randomized, Fasting, Single-dose, 2-sequence, 2-period, Crossover Study to Evaluate the Bioequivalence of YHP2511 With YHP2511A in Healthy Adult Volunteers

Key Details

Gender

All

Age Range

19 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2026-06-23

Completion Date

2026-07-11

Last Updated

2026-03-13

Healthy Volunteers

Yes

Interventions

DRUG

YHP2511

Test drug: YHP2511, Comparator: YHP2511A

DRUG

YHP2511A

Test drug: YHP2511, Comparator: YHP2511A

Locations (1)

H Plus Yangji Hospital

Seoul, South Korea